Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.87M
9 trades · 3 insiders
Net · 90d
$-1.87M
Insiders on file
40
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Reed Joshua | SVP, Chief Financial Officer | 7 | $0 | $0 | 2026-10-08 |
| Whitaker Anne Clem | Director | 2 | $0 | $0 | 2026-10-07 |
| Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | 233 | $0 | $2.40M | 2026-10-02 |
| Hopkinson Craig C. | SVP, Med Dev/Med Affairs, CMO | 223 | $0 | $25.61M | 2026-09-01 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 110 | $0 | $2.58M | 2026-08-17 |
| Jackson Blair Curtis | President & CEO, Alkermes plc, Director | 118 | $0 | $2.25M | 2026-08-05 |
| snyderman nancy lynn MD | Director | 64 | $10.0K | $4.48M | 2026-08-03 |
| Wright Christopher I | Director | 45 | $0 | $90.2K | 2026-06-12 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 52 | $0 | $1.21M | 2026-05-29 |
| GAYNOR RICHARD | Director | 49 | $0 | $0 | 2026-05-21 |
| Cooke Shane | President, Alkermes plc | 263 | $0 | $33.64M | 2026-05-21 |
| Wilson Frank Anders | Director | 47 | $0 | $0 | 2026-05-21 |
| Lurker Nancy | Director | 25 | $0 | $0 | 2026-05-21 |
| LAURENCIN CATO T | Director | 56 | $0 | $343.6K | 2026-05-21 |
| MCKEON BRIAN P | Director | 50 | $264.3K | $0 | 2026-05-21 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 437 | $0 | $127.27M | 2026-03-02 |
| Brown Iain Michael | VP, Finance & CAO | 196 | $0 | $4.92M | 2025-02-26 |
| Daglio David Angelo Jr. | Director | 40 | $815.9K | $0 | 2024-06-29 |
| Alva Emily Peterson | Director | 41 | $49.9K | $0 | 2024-06-29 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 409 | $0 | $26.38M | 2024-02-23 |
| Wysenski Nancy | Director | 39 | $278.7K | $1.29M | 2023-07-07 |
| DIXON WENDY L | Director | 33 | $75.8K | $1.13M | 2022-06-14 |
| ANSTICE DAVID W | Director | 43 | $164.3K | $1.22M | 2022-06-14 |
| MITCHELL PAUL J | Director | 214 | $0 | $6.99M | 2021-05-20 |
| BREYER ROBERT A | Director | 143 | $0 | $8.79M | 2021-05-20 |
| FRATES JAMES M | SVP, Alks Inc; CFO ALKS | 435 | $0 | $34.43M | 2020-05-14 |
| BLOOM FLOYD E | Director | 47 | $351.8K | $5.11M | 2019-05-22 |
| Robinson James A. Jr. | President & COO,Alkermes, Inc. | 7 | $0 | $0 | 2019-04-04 |
| Stejbach Mark | SVP/Chief Comm Off, Alks Inc | 100 | $24.2K | $5.37M | 2018-03-03 |
| BIBERSTEIN KATHRYN L | SVP, GC, Secretary, Alks, Inc. | 202 | $0 | $10.48M | 2018-03-03 |
| Mason Michael | VP, Finance and Treasurer | 3 | $0 | $0 | 2017-12-30 |
| KEATING LAURIE | SVP, GC & Secretary | 8 | $0 | $757.4K | 2017-12-29 |
| Ehrich Elliot | SVP, R&D & CMO, Alkermes, Inc. | 291 | $0 | $28.97M | 2017-05-28 |
| Pugh Gordon G | SVP, COO & CRO, Alkermes, Inc. | 254 | $0 | $30.10M | 2016-12-16 |
| Peterson Rebecca | SVP, Corporate Communications | 143 | $0 | $11.62M | 2015-10-05 |
| HENWOOD GERALDINE | Director | 30 | $0 | $4.08M | 2014-05-28 |
| Botkin James L | SVP, Alkermes Gainesville LLC | 17 | $0 | $1.56M | 2013-12-04 |
| MARAGANORE JOHN | Chief Executive Officer | 1 | $0 | $0 | 2013-09-11 |
| SKALETSKY MARK B | Director | 2 | $0 | $0 | 2013-08-01 |
| Elan Science Three Ltd | 10% Owner | 1 | $0 | $381.57M | 2012-03-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Reed Joshua | SVP, Chief Financial Officer | M Exercise deriv | 2026-10-08 | 2026-10-09 | 9,164 | — | — | 27,492 | SEC↗ |
| Reed Joshua | SVP, Chief Financial Officer | F Tax w/h | 2026-10-08 | 2026-10-09 | 4,069 | $40.11 | $163.2K | 5,095 | SEC↗ |
| Reed Joshua | SVP, Chief Financial Officer | M Exercise | 2026-10-08 | 2026-10-09 | 9,164 | — | — | 9,164 | SEC↗ |
| Whitaker Anne Clem | Director | A Award deriv | 2026-10-07 | 2026-10-09 | 17,998 | — | $0 | 17,998 | SEC↗ |
| Whitaker Anne Clem | Director | A Award deriv | 2026-10-07 | 2026-10-09 | 7,239 | — | $0 | 7,239 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-10-02 | 2026-10-02 | 2,034 | $41.03 | $83.5K | 221,388 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 2,034 | $48.01 | $97.7K | 223,422 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 2,034 | $48.01 | $97.7K | 223,422 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-09-01 | 2026-09-01 | 5,000 | — | $0 | 61,276 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-09-01 | 2026-09-01 | 5,000 | $24.59 | $123.0K | 74,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-09-01 | 2026-09-01 | 9,000 | $46.99 | $422.9K | 65,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-09-01 | 2026-09-01 | 5,000 | — | $0 | 61,276 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-09-01 | 2026-09-01 | 9,000 | $46.99 | $422.9K | 65,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-09-01 | 2026-09-01 | 5,000 | $24.59 | $123.0K | 74,389 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2026-08-17 | 2026-08-17 | 6,912 | $49.19 | $340.0K | 102,857 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2026-08-17 | 2026-08-17 | 664 | $49.65 | $33.0K | 102,193 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2026-08-17 | 2026-08-17 | 664 | $49.65 | $33.0K | 102,193 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2026-08-17 | 2026-08-17 | 6,912 | $49.19 | $340.0K | 102,857 | SEC↗ |
| Jackson Blair Curtis | President & CEO, Alkermes pl | A Award deriv | 2026-08-05 | 2026-08-07 | 124,305 | — | $0 | 124,305 | SEC↗ |
| Jackson Blair Curtis | President & CEO, Alkermes pl | A Award deriv | 2026-08-05 | 2026-08-07 | 93,229 | — | $0 | 93,229 | SEC↗ |
| Jackson Blair Curtis | President & CEO, Alkermes pl | A Award deriv | 2026-08-05 | 2026-08-07 | 124,305 | — | $0 | 124,305 | SEC↗ |
| Jackson Blair Curtis | President & CEO, Alkermes pl | A Award deriv | 2026-08-05 | 2026-08-07 | 93,229 | — | $0 | 93,229 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-08-03 | 2026-08-03 | 4,896 | — | $0 | 66,276 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-08-03 | 2026-08-03 | 104 | — | $0 | 1,252 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise deriv | 2026-08-03 | 2026-08-03 | 16,524 | — | $0 | 0 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise deriv | 2026-08-03 | 2026-08-03 | 27,948 | — | $0 | 0 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-08-03 | 2026-08-03 | 2,034 | $48.58 | $98.8K | 225,456 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-08-03 | 2026-08-03 | 104 | $19.34 | $2.0K | 73,493 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-08-03 | 2026-08-03 | 4,896 | $24.59 | $120.4K | 78,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-08-03 | 2026-08-03 | 9,000 | $48.58 | $437.2K | 69,389 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise | 2026-08-03 | 2026-08-03 | 27,948 | $46.72 | $1.31M | 43,343 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise | 2026-08-03 | 2026-08-03 | 16,524 | $46.72 | $772.0K | 59,867 | SEC↗ |
| snyderman nancy lynn MD | Director | S Sale | 2026-08-03 | 2026-08-03 | 44,472 | $50.35 | $2.24M | 15,395 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise deriv | 2026-08-03 | 2026-08-03 | 16,524 | — | $0 | 0 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise deriv | 2026-08-03 | 2026-08-03 | 27,948 | — | $0 | 0 | SEC↗ |
| snyderman nancy lynn MD | Director | S Sale | 2026-08-03 | 2026-08-03 | 44,472 | $50.35 | $2.24M | 15,395 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise | 2026-08-03 | 2026-08-03 | 16,524 | $46.72 | $772.0K | 59,867 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise | 2026-08-03 | 2026-08-03 | 27,948 | $46.72 | $1.31M | 43,343 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-08-03 | 2026-08-03 | 4,896 | — | $0 | 66,276 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-08-03 | 2026-08-03 | 104 | — | $0 | 1,252 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-08-03 | 2026-08-03 | 9,000 | $48.58 | $437.2K | 69,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-08-03 | 2026-08-03 | 4,896 | $24.59 | $120.4K | 78,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-08-03 | 2026-08-03 | 104 | $19.34 | $2.0K | 73,493 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-08-03 | 2026-08-03 | 2,034 | $48.58 | $98.8K | 225,456 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-07-06 | 2026-07-06 | 2,034 | $54.03 | $109.9K | 227,490 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-07-01 | 2026-07-01 | 5,000 | — | $0 | 1,356 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-07-01 | 2026-07-01 | 5,000 | $19.34 | $96.7K | 82,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-07-01 | 2026-07-01 | 8,300 | $51.46 | $427.1K | 74,089 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-07-01 | 2026-07-01 | 700 | $52.13 | $36.5K | 73,389 | SEC↗ |
| Wright Christopher I | Director | S Sale | 2026-06-12 | 2026-06-12 | 2,000 | $45.10 | $90.2K | 25,680 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-06-04 | 2026-06-04 | 2,034 | $43.05 | $87.6K | 229,524 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-06-01 | 2026-06-01 | 5,000 | — | $0 | 6,356 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-06-01 | 2026-06-01 | 5,000 | $19.34 | $96.7K | 86,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-06-01 | 2026-06-01 | 9,000 | $41.67 | $375.0K | 77,389 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2026-05-29 | 2026-05-29 | 3,392 | — | $0 | 3,394 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2026-05-29 | 2026-05-29 | 12,825 | — | $0 | 12,826 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2026-05-29 | 2026-05-29 | 3,392 | $20.03 | $67.9K | 11,109 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | S Sale | 2026-05-29 | 2026-05-29 | 16,217 | $42.36 | $687.0K | 7,717 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2026-05-29 | 2026-05-29 | 12,825 | $19.34 | $248.0K | 23,934 | SEC↗ |
| Cooke Shane | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| GAYNOR RICHARD | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| LAURENCIN CATO T | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| Lurker Nancy | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| MCKEON BRIAN P | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| Wilson Frank Anders | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| Wright Christopher I | Director | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| Cooke Shane | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 3,207 | $36.95 | $118.5K | 106,679 | SEC↗ |
| Cooke Shane | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 109,886 | SEC↗ |
| GAYNOR RICHARD | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 37,226 | SEC↗ |
| GAYNOR RICHARD | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 35,751 | SEC↗ |
| LAURENCIN CATO T | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 33,769 | SEC↗ |
| LAURENCIN CATO T | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 35,244 | SEC↗ |
| Lurker Nancy | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 19,697 | SEC↗ |
| Lurker Nancy | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 18,222 | SEC↗ |
| MCKEON BRIAN P | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 38,536 | SEC↗ |
| MCKEON BRIAN P | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 40,011 | SEC↗ |
| snyderman nancy lynn MD | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 15,395 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 16,870 | SEC↗ |
| Wilson Frank Anders | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 35,751 | SEC↗ |
| Wilson Frank Anders | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 37,226 | SEC↗ |
| Wright Christopher I | Director | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 27,680 | SEC↗ |
| Wright Christopher I | Director | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 29,155 | SEC↗ |
| Cooke Shane | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| Cooke Shane | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| GAYNOR RICHARD | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| GAYNOR RICHARD | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Cooke Shane | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Cooke Shane | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| GAYNOR RICHARD | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| GAYNOR RICHARD | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| LAURENCIN CATO T | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| LAURENCIN CATO T | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| Lurker Nancy | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| Lurker Nancy | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| MCKEON BRIAN P | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| MCKEON BRIAN P | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| snyderman nancy lynn MD | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| snyderman nancy lynn MD | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| Wilson Frank Anders | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| Wilson Frank Anders | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Wright Christopher I | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| Wright Christopher I | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-05-04 | 2026-05-04 | 2,034 | $33.20 | $67.5K | 231,558 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-05-01 | 2026-05-01 | 5,000 | — | $0 | 11,356 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-05-01 | 2026-05-01 | 9,000 | $33.40 | $300.6K | 81,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-05-01 | 2026-05-01 | 5,000 | $19.34 | $96.7K | 90,389 | SEC↗ |
| Lurker Nancy | Director | M Exercise deriv | 2026-04-11 | 2026-04-13 | 3,751 | — | $0 | 3,752 | SEC↗ |
| Lurker Nancy | Director | M Exercise | 2026-04-11 | 2026-04-13 | 3,751 | — | $0 | 14,456 | SEC↗ |
| Lurker Nancy | Director | F Tax w/h | 2026-04-11 | 2026-04-13 | 901 | $33.36 | $30.1K | 13,555 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-04-06 | 2026-04-06 | 2,034 | $34.57 | $70.3K | 233,592 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-04-01 | 2026-04-01 | 5,000 | — | $0 | 16,356 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-04-01 | 2026-04-01 | 5,000 | $19.34 | $96.7K | 94,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-04-01 | 2026-04-01 | 9,000 | $35.51 | $319.6K | 85,389 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-03-03 | 2026-03-04 | 2,034 | $29.76 | $60.5K | 235,626 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 78,292 | — | $0 | 78,292 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 36,364 | — | $0 | 36,364 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | A Award deriv | 2026-03-02 | 2026-03-04 | 83,037 | — | $0 | 83,037 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | A Award deriv | 2026-03-02 | 2026-03-04 | 38,568 | — | $0 | 38,568 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-03-02 | 2026-03-04 | 5,000 | — | $0 | 21,356 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 94,900 | — | $0 | 94,900 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 44,078 | — | $0 | 44,078 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | A Award deriv | 2026-03-02 | 2026-03-04 | 30,854 | — | $0 | 30,854 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | A Award deriv | 2026-03-02 | 2026-03-04 | 66,430 | — | $0 | 66,430 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | A Award deriv | 2026-03-02 | 2026-03-04 | 14,176 | — | $0 | 14,176 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | A Award deriv | 2026-03-02 | 2026-03-04 | 15,033 | — | $0 | 15,033 | SEC↗ |
| POPS RICHARD F | Director and CEO, Alkermes p | A Award deriv | 2026-03-02 | 2026-03-04 | 88,843 | — | $0 | 88,843 | SEC↗ |
| Reed Joshua | SVP, Chief Financial Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 30,854 | — | $0 | 30,854 | SEC↗ |
| Reed Joshua | SVP, Chief Financial Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 66,430 | — | $0 | 66,430 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 2,034 | $29.29 | $59.6K | 237,660 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-03-02 | 2026-03-04 | 5,000 | $19.34 | $96.7K | 98,389 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-03-02 | 2026-03-04 | 9,000 | $29.72 | $267.5K | 89,389 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2026-03-02 | 2026-03-04 | 6,000 | $30.00 | $180.0K | 109,769 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | S Sale | 2026-03-02 | 2026-03-04 | 6,890 | $29.29 | $201.8K | 7,717 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise deriv | 2026-02-26 | 2026-02-27 | 6,866 | — | $0 | 13,732 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-02-26 | 2026-02-27 | 6,866 | — | $0 | 13,732 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise deriv | 2026-02-26 | 2026-02-27 | 8,322 | — | $0 | 16,645 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise deriv | 2026-02-26 | 2026-02-27 | 5,410 | — | $0 | 10,819 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2026-02-26 | 2026-02-27 | 2,747 | — | $0 | 5,493 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2026-02-26 | 2026-02-27 | 3,049 | $30.73 | $93.7K | 239,694 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise | 2026-02-26 | 2026-02-27 | 6,866 | — | $0 | 242,743 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-02-26 | 2026-02-27 | 6,866 | — | $0 | 96,438 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | F Tax w/h | 2026-02-26 | 2026-02-27 | 3,049 | $30.73 | $93.7K | 93,389 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | F Tax w/h | 2026-02-26 | 2026-02-27 | 3,695 | $30.73 | $113.5K | 241,308 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise | 2026-02-26 | 2026-02-27 | 8,322 | — | $0 | 245,003 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | F Tax w/h | 2026-02-26 | 2026-02-27 | 2,403 | $30.73 | $73.8K | 115,769 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise | 2026-02-26 | 2026-02-27 | 5,410 | — | $0 | 118,172 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | F Tax w/h | 2026-02-26 | 2026-02-27 | 808 | $30.73 | $24.8K | 14,607 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2026-02-26 | 2026-02-27 | 2,747 | — | $0 | 15,415 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise deriv | 2026-02-23 | 2026-02-25 | 7,689 | — | $0 | 7,690 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-02-23 | 2026-02-25 | 7,689 | — | $0 | 7,690 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise deriv | 2026-02-23 | 2026-02-25 | 8,738 | — | $0 | 8,738 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise deriv | 2026-02-23 | 2026-02-25 | 6,407 | — | $0 | 6,408 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2026-02-23 | 2026-02-25 | 2,283 | — | $0 | 2,284 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise | 2026-02-23 | 2026-02-25 | 7,689 | — | $0 | 239,291 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2026-02-23 | 2026-02-25 | 3,414 | $32.19 | $109.9K | 235,877 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | F Tax w/h | 2026-02-23 | 2026-02-25 | 3,414 | $32.19 | $109.9K | 89,572 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-02-23 | 2026-02-25 | 7,689 | — | $0 | 92,986 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | F Tax w/h | 2026-02-23 | 2026-02-25 | 3,880 | $32.19 | $124.9K | 236,681 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise | 2026-02-23 | 2026-02-25 | 8,738 | — | $0 | 240,561 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | F Tax w/h | 2026-02-23 | 2026-02-25 | 2,845 | $32.19 | $91.6K | 112,762 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise | 2026-02-23 | 2026-02-25 | 6,407 | — | $0 | 115,607 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | F Tax w/h | 2026-02-23 | 2026-02-25 | 672 | $32.19 | $21.6K | 12,668 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2026-02-23 | 2026-02-25 | 2,283 | — | $0 | 13,340 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise deriv | 2026-02-19 | 2026-02-20 | 7,673 | — | $0 | 23,019 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-02-19 | 2026-02-20 | 7,673 | — | $0 | 23,019 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise deriv | 2026-02-19 | 2026-02-20 | 9,300 | — | $0 | 27,903 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise deriv | 2026-02-19 | 2026-02-20 | 6,045 | — | $0 | 18,137 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2026-02-19 | 2026-02-20 | 2,991 | — | $0 | 8,974 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise | 2026-02-19 | 2026-02-20 | 7,673 | — | $0 | 235,009 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2026-02-19 | 2026-02-20 | 3,407 | $32.00 | $109.0K | 231,602 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | F Tax w/h | 2026-02-19 | 2026-02-20 | 3,407 | $32.00 | $109.0K | 85,297 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-02-19 | 2026-02-20 | 7,673 | — | $0 | 88,704 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise | 2026-02-19 | 2026-02-20 | 9,300 | — | $0 | 235,953 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | F Tax w/h | 2026-02-19 | 2026-02-20 | 4,130 | $32.00 | $132.2K | 231,823 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise | 2026-02-19 | 2026-02-20 | 6,045 | — | $0 | 111,477 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | F Tax w/h | 2026-02-19 | 2026-02-20 | 2,277 | $32.00 | $72.9K | 109,200 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2026-02-19 | 2026-02-20 | 2,991 | — | $0 | 12,036 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | F Tax w/h | 2026-02-19 | 2026-02-20 | 979 | $32.00 | $31.3K | 11,057 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise deriv | 2026-02-18 | 2026-02-20 | 6,355 | — | $0 | 0 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-02-18 | 2026-02-20 | 8,897 | — | $0 | 0 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise deriv | 2026-02-18 | 2026-02-20 | 8,897 | — | $0 | 0 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise deriv | 2026-02-18 | 2026-02-20 | 6,355 | — | $0 | 0 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2026-02-18 | 2026-02-20 | 2,034 | — | $0 | 0 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise | 2026-02-18 | 2026-02-20 | 6,355 | — | $0 | 229,462 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2026-02-18 | 2026-02-20 | 2,126 | $32.02 | $68.1K | 227,336 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-02-18 | 2026-02-20 | 8,897 | — | $0 | 84,535 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | F Tax w/h | 2026-02-18 | 2026-02-20 | 3,504 | $32.02 | $112.2K | 81,031 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | F Tax w/h | 2026-02-18 | 2026-02-20 | 3,796 | $32.02 | $121.5K | 226,653 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise | 2026-02-18 | 2026-02-20 | 8,897 | — | $0 | 230,449 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise | 2026-02-18 | 2026-02-20 | 6,355 | — | $0 | 107,301 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | F Tax w/h | 2026-02-18 | 2026-02-20 | 1,869 | $32.02 | $59.8K | 105,432 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | F Tax w/h | 2026-02-18 | 2026-02-20 | 706 | $32.02 | $22.6K | 9,045 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2026-02-18 | 2026-02-20 | 2,034 | — | $0 | 9,751 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | A Award | 2026-02-05 | 2026-02-06 | 25,352 | — | $0 | 230,726 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2026-02-05 | 2026-02-06 | 7,619 | $33.55 | $255.6K | 223,107 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | A Award | 2026-02-05 | 2026-02-06 | 25,352 | — | $0 | 83,092 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | F Tax w/h | 2026-02-05 | 2026-02-06 | 7,454 | $33.55 | $250.1K | 75,638 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | A Award | 2026-02-05 | 2026-02-06 | 28,810 | — | $0 | 230,178 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | F Tax w/h | 2026-02-05 | 2026-02-06 | 8,626 | $33.55 | $289.4K | 221,552 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | A Award | 2026-02-05 | 2026-02-06 | 21,127 | — | $0 | 107,335 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | F Tax w/h | 2026-02-05 | 2026-02-06 | 6,389 | $33.55 | $214.4K | 100,946 | SEC↗ |
| POPS RICHARD F | Director and CEO, Alkermes p | A Award | 2026-02-05 | 2026-02-06 | 149,580 | — | $0 | 1,439,970 | SEC↗ |
| POPS RICHARD F | Director and CEO, Alkermes p | F Tax w/h | 2026-02-05 | 2026-02-06 | 62,230 | $33.55 | $2.09M | 1,377,740 | SEC↗ |
| Cooke Shane | Director | M Exercise deriv | 2026-02-02 | 2026-02-02 | 61,200 | — | $0 | 0 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-02-02 | 2026-02-02 | 5,000 | — | $0 | 26,356 | SEC↗ |
| Cooke Shane | Director | S Sale | 2026-02-02 | 2026-02-02 | 29,087 | $34.34 | $998.8K | 135,857 | SEC↗ |
| Cooke Shane | Director | S Sale | 2026-02-02 | 2026-02-02 | 32,113 | $34.78 | $1.12M | 103,744 | SEC↗ |
| Cooke Shane | Director | M Exercise | 2026-02-02 | 2026-02-02 | 61,200 | $31.64 | $1.94M | 164,944 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-02-02 | 2026-02-02 | 4,000 | $33.54 | $134.2K | 57,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-02-02 | 2026-02-02 | 5,000 | $34.24 | $171.2K | 61,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-02-02 | 2026-02-02 | 5,000 | $19.34 | $96.7K | 66,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2026-01-08 | 2026-01-08 | 5,000 | — | $0 | 31,356 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-01-08 | 2026-01-08 | 5,000 | $30.00 | $150.0K | 61,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2026-01-08 | 2026-01-08 | 5,000 | $19.34 | $96.7K | 66,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2026-01-02 | 2026-01-02 | 4,000 | $28.00 | $112.0K | 61,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2025-12-03 | 2025-12-05 | 3,748 | — | $0 | 36,356 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2025-12-03 | 2025-12-05 | 3,748 | $30.00 | $112.4K | 65,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2025-12-03 | 2025-12-05 | 3,748 | $19.34 | $72.5K | 69,488 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2025-12-01 | 2025-12-01 | 4,000 | $29.30 | $117.2K | 65,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2025-11-03 | 2025-11-03 | 5,000 | — | $0 | 40,104 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2025-11-03 | 2025-11-03 | 5,000 | $19.34 | $96.7K | 78,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2025-11-03 | 2025-11-03 | 9,000 | $30.38 | $273.4K | 69,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2025-10-15 | 2025-10-15 | 5,000 | — | $0 | 45,104 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | S Sale | 2025-10-15 | 2025-10-15 | 9,000 | $31.53 | $283.8K | 73,740 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2025-10-15 | 2025-10-15 | 5,000 | $19.34 | $96.7K | 82,740 | SEC↗ |
| Reed Joshua | SVP, Chief Financial Officer | A Award deriv | 2025-10-08 | 2025-10-10 | 158,743 | — | $0 | 158,743 | SEC↗ |
| Reed Joshua | SVP, Chief Financial Officer | A Award deriv | 2025-10-08 | 2025-10-10 | 36,656 | — | $0 | 36,656 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise deriv | 2025-08-03 | 2025-08-04 | 2,014 | — | $0 | 2,015 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise | 2025-08-03 | 2025-08-04 | 2,014 | — | $0 | 206,269 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2025-08-03 | 2025-08-04 | 895 | $26.55 | $23.8K | 205,374 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2025-06-10 | 2025-06-10 | 3,334 | $31.09 | $103.7K | 86,208 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | S Sale | 2025-06-09 | 2025-06-10 | 3,333 | $31.95 | $106.5K | 89,542 | SEC↗ |
| Wright Christopher I | Director | M Exercise deriv | 2025-06-08 | 2025-06-10 | 3,301 | — | $0 | 0 | SEC↗ |
| Wright Christopher I | Director | F Tax w/h | 2025-06-08 | 2025-06-10 | 793 | $31.71 | $25.1K | 23,013 | SEC↗ |
| Wright Christopher I | Director | M Exercise | 2025-06-08 | 2025-06-10 | 3,301 | — | $0 | 23,806 | SEC↗ |
| Cooke Shane | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| GAYNOR RICHARD | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| LAURENCIN CATO T | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| Lurker Nancy | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| MCKEON BRIAN P | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| Wilson Frank Anders | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| Wright Christopher I | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| Cooke Shane | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 4,175 | $30.61 | $127.8K | 103,744 | SEC↗ |
| Cooke Shane | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 107,919 | SEC↗ |
| GAYNOR RICHARD | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 33,008 | SEC↗ |
| GAYNOR RICHARD | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 31,084 | SEC↗ |
| LAURENCIN CATO T | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 31,026 | SEC↗ |
| LAURENCIN CATO T | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 29,102 | SEC↗ |
| Lurker Nancy | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 10,705 | SEC↗ |
| Lurker Nancy | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 12,629 | SEC↗ |
| MCKEON BRIAN P | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 33,869 | SEC↗ |
| MCKEON BRIAN P | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 35,793 | SEC↗ |
| snyderman nancy lynn MD | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 10,728 | SEC↗ |
| snyderman nancy lynn MD | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 12,652 | SEC↗ |
| Wilson Frank Anders | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 31,084 | SEC↗ |
| Wilson Frank Anders | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 33,008 | SEC↗ |
| Wright Christopher I | Director | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 22,429 | SEC↗ |
| Wright Christopher I | Director | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 20,505 | SEC↗ |
| Cooke Shane | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| Cooke Shane | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| GAYNOR RICHARD | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| GAYNOR RICHARD | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| LAURENCIN CATO T | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| LAURENCIN CATO T | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| Lurker Nancy | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| Lurker Nancy | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| MCKEON BRIAN P | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| MCKEON BRIAN P | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| snyderman nancy lynn MD | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| snyderman nancy lynn MD | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| Wilson Frank Anders | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| Wilson Frank Anders | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| Wright Christopher I | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| Wright Christopher I | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| Lurker Nancy | Director | M Exercise deriv | 2025-04-11 | 2025-04-14 | 3,752 | — | $0 | 7,503 | SEC↗ |
| Lurker Nancy | Director | M Exercise deriv | 2025-04-11 | 2025-04-14 | 2,323 | — | $0 | 0 | SEC↗ |
| Lurker Nancy | Director | F Tax w/h | 2025-04-11 | 2025-04-14 | 558 | $27.00 | $15.1K | 1,765 | SEC↗ |
| Lurker Nancy | Director | M Exercise | 2025-04-11 | 2025-04-14 | 3,752 | — | $0 | 5,517 | SEC↗ |
| Lurker Nancy | Director | F Tax w/h | 2025-04-11 | 2025-04-14 | 901 | $27.00 | $24.3K | 4,616 | SEC↗ |
| Lurker Nancy | Director | M Exercise | 2025-04-11 | 2025-04-14 | 2,323 | — | $0 | 2,323 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | S Sale | 2025-02-28 | 2025-02-28 | 1,938 | $34.00 | $65.9K | 7,717 | SEC↗ |
| Brown Iain Michael | SVP, Chief Financial Officer | M Exercise deriv | 2025-02-26 | 2025-02-28 | 5,617 | — | $0 | 16,854 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise deriv | 2025-02-26 | 2025-02-28 | 6,866 | — | $0 | 20,598 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise deriv | 2025-02-26 | 2025-02-28 | 6,866 | — | $0 | 20,598 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise deriv | 2025-02-26 | 2025-02-28 | 8,322 | — | $0 | 24,967 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise deriv | 2025-02-26 | 2025-02-28 | 5,409 | — | $0 | 16,229 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise deriv | 2025-02-26 | 2025-02-28 | 2,746 | — | $0 | 8,240 | SEC↗ |
| Brown Iain Michael | SVP, Chief Financial Officer | F Tax w/h | 2025-02-26 | 2025-02-28 | 2,494 | $34.80 | $86.8K | 148,196 | SEC↗ |
| Brown Iain Michael | SVP, Chief Financial Officer | M Exercise | 2025-02-26 | 2025-02-28 | 5,617 | — | $0 | 150,690 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | F Tax w/h | 2025-02-26 | 2025-02-28 | 3,049 | $34.80 | $106.1K | 204,255 | SEC↗ |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | M Exercise | 2025-02-26 | 2025-02-28 | 6,866 | — | $0 | 207,304 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | M Exercise | 2025-02-26 | 2025-02-28 | 6,866 | — | $0 | 80,789 | SEC↗ |
| Hopkinson Craig C. | EVP R&D, Chief Medical Offic | F Tax w/h | 2025-02-26 | 2025-02-28 | 3,049 | $34.80 | $106.1K | 77,740 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | F Tax w/h | 2025-02-26 | 2025-02-28 | 3,695 | $34.80 | $128.6K | 201,368 | SEC↗ |
| Jackson Blair Curtis | EVP, Chief Operating Officer | M Exercise | 2025-02-26 | 2025-02-28 | 8,322 | — | $0 | 205,063 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | F Tax w/h | 2025-02-26 | 2025-02-28 | 2,402 | $34.80 | $83.6K | 92,875 | SEC↗ |
| Nichols Christian Todd | SVP, Chief Commercial Office | M Exercise | 2025-02-26 | 2025-02-28 | 5,409 | — | $0 | 95,277 | SEC↗ |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | M Exercise | 2025-02-26 | 2025-02-28 | 2,746 | — | $0 | 10,463 | SEC↗ |